Chronic Interstitial Cystitis Clinical Trial
Official title:
Retrospective Evaluation of the Effectiveness of Oral Pentosan Polysulfate Treatment in the Improvement of Chronic Interstitial Cystitis Symptoms.
Verified date | February 2023 |
Source | Hisar Intercontinental Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
To examine the relationship between symptoms and quality of life before and after oral pentosan polysulfate (PPS) treatment in cases diagnosed with interstitial cystitis/painful bladder syndrome (IC/BPS).
Status | Completed |
Enrollment | 37 |
Est. completion date | January 10, 2023 |
Est. primary completion date | December 31, 2021 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Chronic interstitial cystitis - Bladder Pain Syndrome Exclusion Criteria: - Acute cystitis - Bladder cancer - Chronic prostatitis - Bladder stone - Stress incontinence |
Country | Name | City | State |
---|---|---|---|
Turkey | Basri Cakiroglu | Istanbul | |
Turkey | Hisar Intercontinental Hospital | Istanbul |
Lead Sponsor | Collaborator |
---|---|
Hisar Intercontinental Hospital |
Turkey,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | bladder wall thickness | 0.3 over 3 mm 1 under 3 mm, | Three months | |
Primary | improvement of lower urinary tract symptoms | 1 if symptoms improved, 0 if not | Three months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT03143920 -
Hyperbaric Oxygen Therapy for Inflammatory Conditions of the Urinary Bladder
|
Early Phase 1 | |
Recruiting |
NCT06299683 -
Pain Type and Interstitial Cystitis/Bladder Pain Syndrome Treatment
|
N/A | |
Not yet recruiting |
NCT06013449 -
Efficacy of Pulsed Electromagnetic Field and Heparin/Bupivacaine Instillations
|
N/A | |
Not yet recruiting |
NCT04734106 -
Safety and Efficacy of Aloe Vera in the Management of the Symptoms of Interstitial Cystitis
|
Early Phase 1 | |
Active, not recruiting |
NCT02858453 -
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
|
Phase 3 | |
Completed |
NCT01879683 -
A Safety, Tolerability and Preliminary Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis (IC) and Hunner's Lesions
|
Phase 1 | |
Completed |
NCT04275297 -
Optimizing Psychosocial Treatment of Interstitial Cystitis/Bladder Pain Syndrome
|
N/A | |
Completed |
NCT02331472 -
The Efficacy of Urine Biomarker in Patient With Interstitial Cystitis/Painful Bladder Syndrome (Pilot Study)
|
||
Completed |
NCT04540887 -
PEMF Therapy to Treat Interstitial Cystitis/Bladder Pain Syndrome
|
N/A | |
Recruiting |
NCT05149573 -
Investigation of PEMF Therapy for Female Patients With IC/BPS
|
N/A |